189 related articles for article (PubMed ID: 32512517)
1. Association between cellular HIV-1 DNA level and mortality in HIV-1 infected African adults starting ART with high CD4 counts.
N'takpe JB; Gabillard D; Moh R; Gardiennet E; Emieme A; Badje A; Kouame GM; Toni TD; Karcher S; Carrou JL; Ménan H; Danel C; Eholie SP; Rouzioux C; Anglaret X
EBioMedicine; 2020 Jun; 56():102815. PubMed ID: 32512517
[TBL] [Abstract][Full Text] [Related]
2. Association of Plasma Soluble Vascular Cell Adhesion Molecule-1 and sCD14 With Mortality in HIV-1-Infected West African Adults With High CD4 Counts.
Affi R; Gabillard D; Dunyach-Remy C; Ntakpe JB; Moh R; Badje A; Kouame GM; Karcher S; Le Carrou J; Danel C; Chevalier MF; Rouzioux C; Eholie SP; Lavigne JP; Inwoley A; Anglaret X; Weiss L
J Acquir Immune Defic Syndr; 2021 Jan; 86(1):138-145. PubMed ID: 33074857
[TBL] [Abstract][Full Text] [Related]
3. Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial.
Badje A; Moh R; Gabillard D; Guéhi C; Kabran M; Ntakpé JB; Carrou JL; Kouame GM; Ouattara E; Messou E; Anzian A; Minga A; Gnokoro J; Gouesse P; Emieme A; Toni TD; Rabe C; Sidibé B; Nzunetu G; Dohoun L; Yao A; Kamagate S; Amon S; Kouame AB; Koua A; Kouamé E; Daligou M; Hawerlander D; Ackoundzé S; Koule S; Séri J; Ani A; Dembélé F; Koné F; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatunde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Karcher S; Rouzioux C; Kouame A; Assi R; Bakayoko A; Domoua SK; Deschamps N; Aka K; N'Dri-Yoman T; Salamon R; Journot V; Ahibo H; Ouassa T; Menan H; Inwoley A; Danel C; Eholié SP; Anglaret X;
Lancet Glob Health; 2017 Nov; 5(11):e1080-e1089. PubMed ID: 29025631
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 DNA in peripheral blood mononuclear cells is strongly associated with HIV-1 disease progression in recently infected West African adults.
Minga AK; Anglaret X; d' Aquin Toni T; Chaix ML; Dohoun L; Abo Y; Coulibaly A; Duvignac J; Gabillard D; Rouet F; Rouzioux C
J Acquir Immune Defic Syndr; 2008 Jul; 48(3):350-4. PubMed ID: 18545149
[TBL] [Abstract][Full Text] [Related]
5. Plasma sVCAM-1, antiretroviral therapy and mortality in HIV-1-infected West African adults.
Affi R; Gabillard D; Kouame GM; Ntakpe JB; Moh R; Badje A; Danel C; Inwoley A; Eholié SP; Anglaret X; Weiss L
HIV Med; 2022 Aug; 23(7):717-726. PubMed ID: 35023284
[TBL] [Abstract][Full Text] [Related]
6. A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir.
Piketty C; Weiss L; Assoumou L; Burgard M; Mélard A; Ragnaud JM; Bentata M; Girard PM; Rouzioux C; Costagliola D;
J Med Virol; 2010 Nov; 82(11):1819-28. PubMed ID: 20872707
[TBL] [Abstract][Full Text] [Related]
7. Association of cellular HIV-1 DNA and virological success of antiretroviral treatment in HIV-infected sub-Saharan African adults.
Moh DR; Ntakpé JB; Gabillard D; Yayo-Emieme AA; Badjé A; Kouame GM; d'Aquin TT; Danel C; Anglaret X; Eholié SP
BMC Infect Dis; 2022 Jan; 22(1):100. PubMed ID: 35093007
[TBL] [Abstract][Full Text] [Related]
8. Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success.
Alteri C; Scutari R; Stingone C; Maffongelli G; Brugneti M; Falasca F; Martini S; Bertoli A; Turriziani O; Sarmati L; Coppola N; Andreoni M; Santoro MM; Perno CF; Ceccherini-Silberstein F; Svicher V
J Clin Virol; 2019 Aug; 117():61-67. PubMed ID: 31229934
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report.
Frange P; Faye A; Avettand-Fenoël V; Bellaton E; Descamps D; Angin M; David A; Caillat-Zucman S; Peytavin G; Dollfus C; Le Chenadec J; Warszawski J; Rouzioux C; Sáez-Cirión A;
Lancet HIV; 2016 Jan; 3(1):e49-54. PubMed ID: 26762993
[TBL] [Abstract][Full Text] [Related]
10. Human Immunodeficiency Virus Type 1 DNA Decay Dynamics With Early, Long-term Virologic Control of Perinatal Infection.
Uprety P; Patel K; Karalius B; Ziemniak C; Chen YH; Brummel SS; Siminski S; Van Dyke RB; Seage GR; Persaud D;
Clin Infect Dis; 2017 Jun; 64(11):1471-1478. PubMed ID: 28329153
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
[TBL] [Abstract][Full Text] [Related]
12. Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial.
Molina JM; Grund B; Gordin F; Williams I; Schechter M; Losso M; Law M; Ekong E; Mwelase N; Skoutelis A; Wiselka MJ; Vandekerckhove L; Benfield T; Munroe D; Lundgren JD; Neaton JD;
Lancet HIV; 2018 Apr; 5(4):e172-e180. PubMed ID: 29352723
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 CRF01_AE subtype and HIV-1 DNA level among patients with chronic HIV-1 infection: a correlation study.
Lyu T; Yue Y; Hsieh E; Han Y; Zhu T; Song X; Cao W; Lyu W; Wang J; Li T
BMC Infect Dis; 2020 Jan; 20(1):66. PubMed ID: 31964364
[TBL] [Abstract][Full Text] [Related]
14. Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial).
Delaugerre C; Gourlain K; Tubiana R; Carcelain G; Marcelin AG; Chouquet C; Mouroux M; Duvivier C; Autran B; Costagliola D; Katlama C; Calvez V
Antivir Ther; 2003 Jun; 8(3):233-7. PubMed ID: 12924540
[TBL] [Abstract][Full Text] [Related]
15. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
[TBL] [Abstract][Full Text] [Related]
16. Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL.
Gianotti N; Lorenzini P; Cozzi-Lepri A; De Luca A; Madeddu G; Sighinolfi L; Pinnetti C; Santoro C; Meraviglia P; Mussini C; Antinori A; d'Arminio Monforte A;
J Antimicrob Chemother; 2019 Sep; 74(9):2732-2741. PubMed ID: 31173639
[TBL] [Abstract][Full Text] [Related]
17. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.
Kouamé GM; Boyd A; Moh R; Badje A; Gabillard D; Ouattara E; Ntakpe JB; Emième A; Maylin S; Chekaraou MA; Eholié SP; Zoulim F; Lacombe K; Anglaret X; Danel C;
Clin Infect Dis; 2018 Jan; 66(1):112-120. PubMed ID: 29020361
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of cellular HIV-1 DNA levels over 144 weeks of darunavir/ritonavir monotherapy versus triple therapy in the MONET trial.
Geretti AM; Arribas JR; Lathouwers E; Foster GM; Yakoob R; Kinloch S; Hill A; van Delft Y; Moecklinghoff C
HIV Clin Trials; 2013; 14(1):45-50. PubMed ID: 23372114
[TBL] [Abstract][Full Text] [Related]
19. Impact of Different Antiretroviral Strategies on Total HIV-DNA Level in Virologically Suppressed HIV-1 Infected Patients.
Bon I; Calza L; Musumeci G; Longo S; Bertoldi A; D'Urbano V; Gibellini D; Magistrelli E; Viale PL; Re MC
Curr HIV Res; 2017; 15(6):448-455. PubMed ID: 29210661
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.
Okomo U; Togun T; Oko F; Peterson K; Townend J; Peterson I; Jaye A
BMC Pediatr; 2012 Jul; 12():95. PubMed ID: 22770231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
